SUSAN ABUGHOSH to Retrospective Studies
This is a "connection" page, showing publications SUSAN ABUGHOSH has written about Retrospective Studies.
Connection Strength
1.583
-
Effect of initial combination therapy vs. step-therapy on adherence and persistence in drug na?ve type 2 diabetes patients. J Diabetes Complications. 2025 Sep; 39(9):109080.
Score: 0.065
-
Treatment refractoriness and response rates in patients with relapsed/refractory multiple myeloma: a retrospective analysis of real-world data. Cancer Treat Res Commun. 2025; 43:100921.
Score: 0.064
-
Marginal structural models to evaluate the association between adherence to direct oral anticoagulants and safety or efficacy outcomes among patients with atrial fibrillation. J Am Pharm Assoc (2003). 2025 May-Jun; 65(3):102355.
Score: 0.064
-
Real-world treatment patterns in drug na?ve type 2 diabetes population: Initial combination therapy vs. sequential step-therapy. J Am Pharm Assoc (2003). 2025 Jan-Feb; 65(1):102295.
Score: 0.063
-
Group-based trajectory modeling to identify adherence patterns for direct oral anticoagulants in Medicare beneficiaries with atrial fibrillation: a real-world study on medication adherence. Int J Clin Pharm. 2024 Dec; 46(6):1525-1535.
Score: 0.062
-
Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation. J Manag Care Spec Pharm. 2024 May; 30(5):408-419.
Score: 0.060
-
Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas. Patient Educ Couns. 2024 Feb; 119:108073.
Score: 0.058
-
A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Drugs Aging. 2023 04; 40(4):377-390.
Score: 0.056
-
Evaluating Adherence to Concomitant Diabetes, Hypertension, and Hyperlipidemia Treatments and Cardiovascular Outcomes Among Elderly Patients Using Marginal Structural Modeling. High Blood Press Cardiovasc Prev. 2022 Nov; 29(6):601-610.
Score: 0.054
-
Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study. Int J Clin Pharm. 2022 Aug; 44(4):966-974.
Score: 0.053
-
Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling. Pharmacotherapy. 2022 07; 42(7):518-528.
Score: 0.053
-
Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1351-1358.
Score: 0.052
-
Using group-based trajectory modeling to characterize the association of past ACEIs/ARBs adherence with subsequent statin adherence patterns among new statin users. J Am Pharm Assoc (2003). 2021 Nov-Dec; 61(6):829-837.e2.
Score: 0.050
-
Identifying adherent patients to newly initiated statins using previous adherence to chronic medications. J Manag Care Spec Pharm. 2021 Feb; 27(2):186-197.
Score: 0.048
-
Impact of a motivational interviewing intervention targeting statins on adherence to concurrent hypertension or diabetes medications. Patient Educ Couns. 2021 07; 104(7):1756-1764.
Score: 0.048
-
Risk of Cardiovascular Outcomes and Antihypertensive Triple Combination Therapy Among Elderly Patients with Hypertension Enrolled in a Medicare Advantage Plan (MAP). Am J Cardiovasc Drugs. 2020 Dec; 20(6):591-602.
Score: 0.048
-
Evaluating trajectories of statin adherence after a motivational interviewing intervention. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):892-898.
Score: 0.046
-
A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy. Medicine (Baltimore). 2020 Apr; 99(16):e19603.
Score: 0.045
-
Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence. J Manag Care Spec Pharm. 2019 Oct; 25(10):1053-1062.
Score: 0.044
-
Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan. J Manag Care Spec Pharm. 2019 Jun; 25(6):678-686.
Score: 0.043
-
Comparison of Suicide Attempts/Behaviors Following Smoking Cessation Treatments Among Schizophrenic Smokers. Arch Psychiatr Nurs. 2017 02; 31(1):62-67.
Score: 0.035
-
Comparative Effectiveness of Smoking Cessation Medications to Attenuate Weight Gain Following Cessation. Subst Use Misuse. 2016; 51(5):586-97.
Score: 0.034
-
Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers. Subst Use Misuse. 2015; 50(13):1628-37.
Score: 0.034
-
The relationship between obesity and prescription of smoking cessation medications. Popul Health Manag. 2014 Jun; 17(3):172-9.
Score: 0.030
-
Predictors of smoking cessation medication use among nonobese and obese smokers. Subst Use Misuse. 2014 May; 49(6):752-61.
Score: 0.030
-
Differences in obesity management among physicians. Popul Health Manag. 2012 Oct; 15(5):287-92.
Score: 0.027
-
Decreased persistence to cholinesterase inhibitor therapy with concomitant use of drugs that can impair cognition. Pharmacotherapy. 2005 Dec; 25(12):1729-35.
Score: 0.017
-
Non-adherence of cyclin-dependent kinases 4 and 6 inhibitors reduces overall and progression-free survival in patients with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2025 Jul; 212(1):71-78.
Score: 0.016
-
Does Concomitant Psychostimulants Mitigate Second-Generation Antipsychotics-Associated Weight Gain? An Observational Study Based on Electronic Medical Records Data. J Child Adolesc Psychopharmacol. 2025 Nov; 35(9):508-517.
Score: 0.016
-
Concurrent Depression Management in Patients with Opioid Use Disorder Undergoing Buprenorphine Therapy: Association with Buprenorphine Discontinuation. J Dual Diagn. 2025 Apr; 21(2):142-151.
Score: 0.016
-
Racial and Ethnic Disparities in Access to Care Among Adults with Cardiovascular Disease. J Health Care Poor Underserved. 2025; 36(1):96-114.
Score: 0.016
-
Racial and Ethnic Disparities in Perceived Health Status Among Patients With Cardiovascular Disease. Prev Chronic Dis. 2024 Nov 14; 21:E89.
Score: 0.016
-
Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients. J Manag Care Pharm. 2004 Sep-Oct; 10(5):404-11.
Score: 0.015
-
Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study. Support Care Cancer. 2024 Jun 04; 32(7):407.
Score: 0.015
-
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors. Drugs Aging. 2024 Apr; 41(4):339-355.
Score: 0.015
-
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics. J Child Adolesc Psychopharmacol. 2024 05; 34(4):201-209.
Score: 0.015
-
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents. J Clin Psychopharmacol. 2024 Mar-Apr 01; 44(2):124-132.
Score: 0.015
-
Adherence to Recommended Metabolic Monitoring of Children and Adolescents Taking Second-Generation Antipsychotics. Psychiatr Serv. 2024 Apr 01; 75(4):342-348.
Score: 0.014
-
Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescents. J Psychiatr Res. 2023 09; 165:170-173.
Score: 0.014
-
Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic. Int J Clin Pharm. 2023 Dec; 45(6):1396-1404.
Score: 0.014
-
Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer in the United States: A SEER-Medicare population-based study. Cancer. 2023 04 01; 129(7):1051-1063.
Score: 0.014
-
Patterns of Lipid Lowering Therapy Use Among Older Adults in a Managed Care Advantage Plan in the United States. J Pharm Pract. 2024 Feb; 37(1):123-131.
Score: 0.014
-
Association of Puberty Stage and Weight Status with Cardiometabolic Risk in Children and Adolescents Living on the Texas-Mexico Border. Metab Syndr Relat Disord. 2022 10; 20(8):440-450.
Score: 0.013
-
Switching pharmacies leads to gaps in medication possession in individuals treated with buprenorphine. J Am Pharm Assoc (2003). 2021 Sep-Oct; 61(5):589-595.
Score: 0.012
-
Association of the Healthcare Effectiveness Data and Information Set (HEDIS) Follow-Up Care Measures and Medication Adherence Among Medicaid Insured Children with ADHD. J Atten Disord. 2022 Feb; 26(3):370-376.
Score: 0.012
-
Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution. Clin Breast Cancer. 2020 12; 20(6):520-526.
Score: 0.012
-
Effect of coverage gap on healthcare utilization among Medicare beneficiaries with chronic obstructive pulmonary disorder. Curr Med Res Opin. 2019 02; 35(2):321-328.
Score: 0.010
-
Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider Acceptance. J Manag Care Spec Pharm. 2016 Jan; 22(1):49-55.
Score: 0.008
-
The Role of Socioeconomic Status and Health Care Access in Breast Cancer Screening Compliance Among Hispanics. J Public Health Manag Pract. 2015 Sep-Oct; 21(5):467-76.
Score: 0.008